Morley Device Innovations & Life2 Partner On New Software Medical Devices

Share Article

Artificial Intelligence & Machine Learning Drive Innovation

Life2’s artificial intelligence technology opens the door for exciting new software medical devices.

Morley Device Innovations, (MDI), an affiliate of Morley Research Consortium, an Atlanta-based Contract Research Organization and Life2, Inc., an innovator in artificial intelligence, machine learning and clinical data services announced a partnership to bring artificial intelligence-based medical devices to market. The partnership’s initial effort focuses on early detection of infectious diseases and other clinical conditions that affect patients in acute care hospitals.

Donald A. Johnson, Managing Director of MDI stated: “Life2’s artificial intelligence technology opens the door for exciting new software medical devices. MDI has deep experience in clinical trials, medical device technologies, pharmaceuticals, and healthcare in international markets. Our team looks forward to working with Life2 to bring new device innovation to the healthcare markets. We are actively conducting clinical trials for several new product ideas and hope to receive our first of many FDA 510k medical devices later this year.”

Life2’s Artificial Intelligence Engine provides hospitals empirical evidence of which clinical and procedural actions are most effective. It utilizes artificial intelligence, deep machine learning, cognitive augmentation and expert guidance to deliver real time patient based risk stratification, causality analysis and empirical intervention selection. An Evidence Engine powers an automated Machine Learning Feedback Loop that compiles the outcomes and measures the effectiveness of each action. This results in real time “course correction”, helping hospitals and clinicians optimize patient outcomes as well as quality and financial performance while reducing risk.

Sam Wilkes, Founder and Chairman of Life2 stated: “Our technology has been effectively used to mitigate operational risks at acute care hospitals. These include reducing length of stay and readmissions while optimizing reimbursements and post acute venue selection. We are rapidly adding a broad base of clinical capabilities to our platform. These insights will help hospital Care Teams predict and mitigate clinical risks of their patients on a real time basis. The end result is higher quality of care and improved hospital financial performance. Our technology fits perfectly into the world of medical devices and we are very excited to partner with MDI on new device innovations.”

About Morley Device Innovations: Morley Device Innovations (MDI) is a team of seasoned investors, clinical and regulatory affairs specialists, scientists, researchers and industry veterans. MDI is an affiliate of Morley Research Consortium, an Atlanta, GA-based Contract Research Organization, with offices in Atlanta, Georgia, Redwood City, California (Silicon Valley), Boston, MA, Tokyo, Japan and Shanghai, China. MDI invests in early to mid-stage healthcare companies globally to leverage its vast experience of getting products through worldwide regulatory entities. MDI uses the skill sets, experience, and health care industry connectivity of a team uniquely capable of acquiring, refining, and validating medical devices, thereby significantly enhancing the commercial value of its assets. MDI's business model mitigates the variables and risk of traditional venture investing. MDI’s global ecosystem of contacts and affiliates allows us to source, analyze, invest and exit in shorter time frames with our own internal team from beginning to end of a product life cycle.

About Life2: Life2 is an innovator in artificial intelligence, machine learning and clinical data services. The company’s Artificial Intelligence Cycle focuses on the financial and operational risks facing acute care hospitals and their care continuum partners. The platform analyzes and calculates – via empirical evidence – “which actions work and which do not”. It provides real time “course correction”, helping hospitals optimize patient outcomes, quality and financial performance. The platform complements all of the hospital’s existing management systems by feeding valuable proactive insights via normal hospital workflow. Please visit to learn more.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Rick Egan
Life2, Inc.
+1 (404) 805-1812
Email >
Follow >
Visit website